Selected research
Market Analysis & Forecast
Global Pharmaceutical Active and Intelligent Packaging Market Analysis and Forecast 2026-2032
Market perspective
The global Pharmaceutical Active and Intelligent Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pharmaceutical Active and Intelligent Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pharmaceutical Active and Intelligent Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pharmaceutical Active and Intelligent Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pharmaceutical Active and Intelligent Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pharmaceutical Active and Intelligent Packaging include BASF, WestRock Company, Timestrip UK, Sonoco Products, Sealed Air Corporation, Landec, Honeywell International, Graphic Packaging and Dessicare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical Active and Intelligent Packaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharmaceutical Active and Intelligent Packaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Active and Intelligent Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Active and Intelligent Packaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Active and Intelligent Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Active and Intelligent Packaging revenue, projected growth trends, production technology, application and end-user industry.
Pharmaceutical Active and Intelligent Packaging Segment by Company
BASF
WestRock Company
Timestrip UK
Sonoco Products
Sealed Air Corporation
Landec
Honeywell International
Graphic Packaging
Dessicare
Crown Holdings
Coveris Holdings
CCL Industrie
Bemis Company
Ball Corporation
Amcor
Pharmaceutical Active and Intelligent Packaging Segment by Type
Active Packaging
Intelligent Packaging
Pharmaceutical Active and Intelligent Packaging Segment by Application
Human Medicine
Veterinary Medicine
Pharmaceutical Active and Intelligent Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Active and Intelligent Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Active and Intelligent Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Active and Intelligent Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmaceutical Active and Intelligent Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmaceutical Active and Intelligent Packaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Active and Intelligent Packaging revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Active Packaging
- Intelligent Packaging
Applications
- Human Medicine
- Veterinary Medicine
Companies covered
- BASF
- WestRock Company
- Timestrip UK
- Sonoco Products
- Sealed Air Corporation
- Landec
- Honeywell International
- Graphic Packaging
- Dessicare
- Crown Holdings
- Coveris Holdings
- CCL Industrie
- Bemis Company
- Ball Corporation
- Amcor
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharmaceutical Active and Intelligent Packaging Market by Type
- 1.2.1 Global Pharmaceutical Active and Intelligent Packaging Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Active Packaging
- 1.2.3 Intelligent Packaging
- 1.3 Pharmaceutical Active and Intelligent Packaging Market by Application
- 1.3.1 Global Pharmaceutical Active and Intelligent Packaging Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Human Medicine
- 1.3.3 Veterinary Medicine
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Active and Intelligent Packaging Market Dynamics
- 2.1 Pharmaceutical Active and Intelligent Packaging Industry Trends
- 2.2 Pharmaceutical Active and Intelligent Packaging Industry Drivers
- 2.3 Pharmaceutical Active and Intelligent Packaging Industry Opportunities and Challenges
- 2.4 Pharmaceutical Active and Intelligent Packaging Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pharmaceutical Active and Intelligent Packaging Market Perspective (2021-2032)
- 3.2 Global Pharmaceutical Active and Intelligent Packaging Growth Trends by Region
- 3.2.1 Global Pharmaceutical Active and Intelligent Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharmaceutical Active and Intelligent Packaging Market Size by Region (2021-2026)
- 3.2.3 Global Pharmaceutical Active and Intelligent Packaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pharmaceutical Active and Intelligent Packaging Revenue by Players
- 4.1.1 Global Pharmaceutical Active and Intelligent Packaging Revenue by Players (2021-2026)
- 4.1.2 Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pharmaceutical Active and Intelligent Packaging Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharmaceutical Active and Intelligent Packaging Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pharmaceutical Active and Intelligent Packaging Key Players Headquarters & Area Served
- 4.4 Global Pharmaceutical Active and Intelligent Packaging Players, Product Type & Application
- 4.5 Global Pharmaceutical Active and Intelligent Packaging Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pharmaceutical Active and Intelligent Packaging Market CR5 and HHI
- 4.6.3 2025 Pharmaceutical Active and Intelligent Packaging Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Active and Intelligent Packaging Market Size by Type
- 5.1 Global Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 5.3 Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Active and Intelligent Packaging Market Size by Application
- 6.1 Global Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 6.3 Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 BASF
- 7.1.1 BASF Company Information
- 7.1.2 BASF Business Overview
- 7.1.3 BASF Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.1.4 BASF Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.1.5 BASF Recent Developments
- 7.2 WestRock Company
- 7.2.1 WestRock Company Company Information
- 7.2.2 WestRock Company Business Overview
- 7.2.3 WestRock Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.2.4 WestRock Company Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.2.5 WestRock Company Recent Developments
- 7.3 Timestrip UK
- 7.3.1 Timestrip UK Company Information
- 7.3.2 Timestrip UK Business Overview
- 7.3.3 Timestrip UK Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.3.4 Timestrip UK Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.3.5 Timestrip UK Recent Developments
- 7.4 Sonoco Products
- 7.4.1 Sonoco Products Company Information
- 7.4.2 Sonoco Products Business Overview
- 7.4.3 Sonoco Products Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.4.4 Sonoco Products Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.4.5 Sonoco Products Recent Developments
- 7.5 Sealed Air Corporation
- 7.5.1 Sealed Air Corporation Company Information
- 7.5.2 Sealed Air Corporation Business Overview
- 7.5.3 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.5.4 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.5.5 Sealed Air Corporation Recent Developments
- 7.6 Landec
- 7.6.1 Landec Company Information
- 7.6.2 Landec Business Overview
- 7.6.3 Landec Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.6.4 Landec Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.6.5 Landec Recent Developments
- 7.7 Honeywell International
- 7.7.1 Honeywell International Company Information
- 7.7.2 Honeywell International Business Overview
- 7.7.3 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.7.4 Honeywell International Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.7.5 Honeywell International Recent Developments
- 7.8 Graphic Packaging
- 7.8.1 Graphic Packaging Company Information
- 7.8.2 Graphic Packaging Business Overview
- 7.8.3 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.8.4 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.8.5 Graphic Packaging Recent Developments
- 7.9 Dessicare
- 7.9.1 Dessicare Company Information
- 7.9.2 Dessicare Business Overview
- 7.9.3 Dessicare Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.9.4 Dessicare Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.9.5 Dessicare Recent Developments
- 7.10 Crown Holdings
- 7.10.1 Crown Holdings Company Information
- 7.10.2 Crown Holdings Business Overview
- 7.10.3 Crown Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.10.4 Crown Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.10.5 Crown Holdings Recent Developments
- 7.11 Coveris Holdings
- 7.11.1 Coveris Holdings Company Information
- 7.11.2 Coveris Holdings Business Overview
- 7.11.3 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.11.4 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.11.5 Coveris Holdings Recent Developments
- 7.12 CCL Industrie
- 7.12.1 CCL Industrie Company Information
- 7.12.2 CCL Industrie Business Overview
- 7.12.3 CCL Industrie Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.12.4 CCL Industrie Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.12.5 CCL Industrie Recent Developments
- 7.13 Bemis Company
- 7.13.1 Bemis Company Company Information
- 7.13.2 Bemis Company Business Overview
- 7.13.3 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.13.4 Bemis Company Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.13.5 Bemis Company Recent Developments
- 7.14 Ball Corporation
- 7.14.1 Ball Corporation Company Information
- 7.14.2 Ball Corporation Business Overview
- 7.14.3 Ball Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.14.4 Ball Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.14.5 Ball Corporation Recent Developments
- 7.15 Amcor
- 7.15.1 Amcor Company Information
- 7.15.2 Amcor Business Overview
- 7.15.3 Amcor Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
- 7.15.4 Amcor Pharmaceutical Active and Intelligent Packaging Product Portfolio
- 7.15.5 Amcor Recent Developments
8 North America
- 8.1 North America Pharmaceutical Active and Intelligent Packaging Revenue (2021-2032)
- 8.2 North America Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 8.2.1 North America Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2026)
- 8.2.2 North America Pharmaceutical Active and Intelligent Packaging Revenue by Type (2027-2032)
- 8.3 North America Pharmaceutical Active and Intelligent Packaging Revenue Share by Type (2021-2032)
- 8.4 North America Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 8.4.1 North America Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2026)
- 8.4.2 North America Pharmaceutical Active and Intelligent Packaging Revenue by Application (2027-2032)
- 8.5 North America Pharmaceutical Active and Intelligent Packaging Revenue Share by Application (2021-2032)
- 8.6 North America Pharmaceutical Active and Intelligent Packaging Revenue by Country
- 8.6.1 North America Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021-2026)
- 8.6.3 North America Pharmaceutical Active and Intelligent Packaging Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pharmaceutical Active and Intelligent Packaging Revenue (2021-2032)
- 9.2 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 9.2.1 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2026)
- 9.2.2 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Type (2027-2032)
- 9.3 Europe Pharmaceutical Active and Intelligent Packaging Revenue Share by Type (2021-2032)
- 9.4 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 9.4.1 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2026)
- 9.4.2 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Application (2027-2032)
- 9.5 Europe Pharmaceutical Active and Intelligent Packaging Revenue Share by Application (2021-2032)
- 9.6 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Country
- 9.6.1 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021-2026)
- 9.6.3 Europe Pharmaceutical Active and Intelligent Packaging Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pharmaceutical Active and Intelligent Packaging Revenue (2021-2032)
- 10.2 China Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 10.2.1 China Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2026)
- 10.2.2 China Pharmaceutical Active and Intelligent Packaging Revenue by Type (2027-2032)
- 10.3 China Pharmaceutical Active and Intelligent Packaging Revenue Share by Type (2021-2032)
- 10.4 China Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 10.4.1 China Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2026)
- 10.4.2 China Pharmaceutical Active and Intelligent Packaging Revenue by Application (2027-2032)
- 10.5 China Pharmaceutical Active and Intelligent Packaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharmaceutical Active and Intelligent Packaging Revenue (2021-2032)
- 11.2 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 11.2.1 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2026)
- 11.2.2 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Type (2027-2032)
- 11.3 Asia Pharmaceutical Active and Intelligent Packaging Revenue Share by Type (2021-2032)
- 11.4 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 11.4.1 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2026)
- 11.4.2 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Application (2027-2032)
- 11.5 Asia Pharmaceutical Active and Intelligent Packaging Revenue Share by Application (2021-2032)
- 11.6 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Country
- 11.6.1 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021-2026)
- 11.6.3 Asia Pharmaceutical Active and Intelligent Packaging Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue (2021-2032)
- 12.2 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Type (2027-2032)
- 12.3 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Application (2027-2032)
- 12.5 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Country
- 12.6.1 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pharmaceutical Active and Intelligent Packaging Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst